Edward H.  Myles net worth and biography

Edward Myles Biography and Net Worth

CFO of Scholar Rock
Currently, Edward H. Myles occupies the position of Chief Financial Officer & Head-Business Operations at Scholar Rock Holding Corp. and Chief Financial Officer & Head-Business Operations at Scholar Rock, Inc. (a subsidiary of Scholar Rock Holding Corp.) and Chief Financial Officer, Treasurer & Director at AMAG Pharma USA, Inc. Mr. Myles is also Treasurer & Director at School On Wheels of Massachusetts.

He previously held the position of Chief Financial Officer & SVP-Finance at Pressure BioSciences, Inc., Principal at Merck KGaA and Controller at EMD Pharmaceuticals, Inc. (a subsidiary of Merck KGaA), Chief Operating & Financial Officer of Astellas Institute for Regenerative Medicine, Chief Financial Officer & VP-Operations at PrimeraDx, Inc., COO, Chief Financial Officer, Treasurer & EVP at AMAG Pharmaceuticals, Inc., Senior Associate at PricewaterhouseCoopers LLP, Associate-Healthcare Investment Banking Group at SG Cowen Securities Corp. and Controller for Boston Biomedical, Inc.

Edward H. Myles received an undergraduate degree from the University of Hartford and an MBA from Olin Business School.

What is Edward H. Myles' net worth?

The estimated net worth of Edward H. Myles is at least $6.11 million as of October 7th, 2024. Mr. Myles owns 161,088 shares of Scholar Rock stock worth more than $6,114,900 as of December 3rd. This net worth estimate does not reflect any other investments that Mr. Myles may own. Additionally, Mr. Myles receives an annual salary of $720,790.00 as CFO at Scholar Rock. Learn More about Edward H. Myles' net worth.

How old is Edward H. Myles?

Mr. Myles is currently 52 years old. There are 5 older executives and no younger executives at Scholar Rock. The oldest executive at Scholar Rock is Dr. Jay Thomas Backstrom M.D., M.P.H., President, CEO & Director, who is 69 years old. Learn More on Edward H. Myles' age.

What is Edward H. Myles' salary?

As the CFO of Scholar Rock Holding Co., Mr. Myles earns $720,790.00 per year. The highest earning executive at Scholar Rock is Dr. Jay Thomas Backstrom M.D., M.P.H., President, CEO & Director, who commands a salary of $1,070,000.00 per year. Learn More on Edward H. Myles' salary.

How do I contact Edward H. Myles?

The corporate mailing address for Mr. Myles and other Scholar Rock executives is 620 MEMORIAL DRIVE 2ND FLOOR, CAMBRIDGE MA, 02139. Scholar Rock can also be reached via phone at (857) 259-3860 and via email at [email protected]. Learn More on Edward H. Myles' contact information.

Has Edward H. Myles been buying or selling shares of Scholar Rock?

During the last quarter, Edward H. Myles has sold $5,477,734.40 in Scholar Rock stock. Most recently, Edward H. Myles sold 206,240 shares of the business's stock in a transaction on Monday, October 7th. The shares were sold at an average price of $26.56, for a transaction totalling $5,477,734.40. Following the completion of the sale, the chief financial officer now directly owns 161,088 shares of the company's stock, valued at $4,278,497.28. Learn More on Edward H. Myles' trading history.

Who are Scholar Rock's active insiders?

Scholar Rock's insider roster includes Jeffrey Flier (Director), and Edward Myles (CFO). Learn More on Scholar Rock's active insiders.

Are insiders buying or selling shares of Scholar Rock?

In the last year, insiders at the sold shares 17 times. They sold a total of 1,887,544 shares worth more than $57,342,536.85. The most recent insider tranaction occured on November, 25th when Major Shareholder Public Equities L.P. Invus sold 409,433 shares worth more than $15,759,076.17. Insiders at Scholar Rock own 19.2% of the company. Learn More about insider trades at Scholar Rock.

Information on this page was last updated on 11/25/2024.

Edward H. Myles Insider Trading History at Scholar Rock

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/7/2024Sell206,240$26.56$5,477,734.40161,088View SEC Filing Icon  
6/17/2024Sell9,458$8.98$84,932.84201,518View SEC Filing Icon  
2/16/2024Sell4,744$15.74$74,670.56210,976View SEC Filing Icon  
1/16/2024Sell6,634$15.93$105,679.62162,150View SEC Filing Icon  
12/29/2023Sell12,459$18.83$234,602.97168,784View SEC Filing Icon  
11/2/2023Sell35,007$12.51$437,937.57168,784View SEC Filing Icon  
11/15/2021Sell4,879$35.05$171,008.95View SEC Filing Icon  
11/11/2021Sell23,574$35.20$829,804.80View SEC Filing Icon  
See Full Table

Edward H. Myles Buying and Selling Activity at Scholar Rock

This chart shows Edward H Myles's buying and selling at Scholar Rock by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Scholar Rock Company Overview

Scholar Rock logo
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Read More

Today's Range

Now: $39.06
Low: $37.38
High: $39.13

50 Day Range

MA: $26.08
Low: $7.07
High: $39.90

2 Week Range

Now: $39.06
Low: $6.76
High: $43.38

Volume

123,449 shs

Average Volume

1,146,619 shs

Market Capitalization

$3.66 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.57